The TGFBR1*6A allelic frequency also ranged from 6.1 to 12.8% among breast cancer patients from northern and southwestern Europe, including samples from the UK36, Spain32, Sweden37, Finland38, Poland38,39, and Ireland40 (Table 1). This evidence concerns the gene TGFBR1 and breast cancer.